Author: Ken Dropiewski

CryoLife Announces Offering of Convertible Senior Notes Due 2025

ATLANTA, June 18, 2020 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY) (“CryoLife” or “the Company”), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market conditions and other factors, $100,000,000 aggregate principal amount of convertible senior notes due 2025 (the “Notes”) in a private placement to qualified […]

Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.

DUBLIN, Ireland and BRIDGEWATER, N.J., June 16, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) announced today a settlement agreement with Apotex Inc. (Apotex) that resolves patent litigation that would have resulted from the previously disclosed abbreviated new drug application (ANDA) filed by Apotex with U.S. Food and Drug Administration […]

Huami’s Next Wearable AI Chip Huangshan-2 Scheduled for Mass Production in Q4, 2020, 50% Energy Saved with Faster Atrial Fibrillation Detection

Ramesh Jain – Father of Multimedia Computing Appointed as Chief Technical Advisor of Huami AI Research Institute, Announced on Huami’s 1st Innovation Conference “AI to Decode Future” SHENZHEN, China, June 17, 2020 /PRNewswire/ — The Global Top 5 wearable brand[1], Amazfit’s mother company, Huami (NYSE: HMI) , made its second wearable AI chip […]

ABRE Study Meets Primary Safety and Effectiveness Endpoints

Medtronic Self-Expanding Venous Stent Demonstrates Favorable Outcomes in Patients with Venous Outflow Obstruction DUBLIN and LONDON, June 16, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre™ venous […]

INFINITY ANGIOPLASTY BALLOON CATHETER™ RECEIVES 510(k) CLEARANCE

[Dateline: Toledo, Ohio, June, 2020]-INFINITY ANGIOPLASTY BALLOON CO., announced today that its innovative balloon platform – INFINITY ANGIOPLASTY BALLOON CATHETER™ has been cleared by the FDA for PTA treatment of peripheral arterial disease, in peripheral vasculature including iliac, femoral, popliteal, infra-popliteal arteries and for the treatment of AV dialysis fistulae.   […]

Endologix Issues Correction Notice for Ovation iX Abdominal Stent Graft System

IRVINE, Calif.–(BUSINESS WIRE)–Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that a correction notice has been issued for the Ovation iX system, that identifies the root cause of polymer leaks. This voluntary action has been classified by the FDA […]

CardioFocus® Announces Initial Commercial Procedures Following US FDA Approval of HeartLight® X3 System for the Treatment of Atrial Fibrillation

MARLBOROUGH, Mass., June 16, 2020 /PRNewswire/ — CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System. The revolutionary cardiac ablation technology is designed to treat drug refractory, symptomatic paroxysmal atrial fibrillation (AFib), the most common heart rhythm disorder. Henry D. Huang, M.D., FACC, […]

Introducing The StopAfib.org Library Collection of No-Cost Videos for Atrial Fibrillation Patients

DALLAS, June 16, 2020 /PRNewswire/ — The StopAfib.org Library, an invaluable collection of video resources for people living with atrial fibrillation (afib), is now available at no cost. The world-renowned StopAfib.org patient advocacy organization empowers those living with afib to take control of their treatment and get their lives back. This one-stop source […]